The role of stress in PCOS

References

• Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome. In: Givens JHF, Merriman G, editors. The polycystic ovary syndrome. Cambridge (MA): Blackwell Scientific; 1992. p. 377–384.
   Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19–25.
   Web of Science ®Google Scholar
• Azziz R, Carmina E, DeWailly D, et al. Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J Clin Endocrinol Metab. 2006;91:4237–4245.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab. 1999 Nov;84(11):4006–4011.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012 Dec;33(6):981–1030.
   PubMed Web of Science ®Google Scholar
• Deeks AA, Gibson-Helm ME, Paul E, et al. Is having polycystic ovary syndrome a predictor of poor psychological function including anxiety and depression? Hum Reprod. 2011 Jun;26(6):1399–1407.
   PubMed Web of Science ®Google Scholar
• Dokras A. Mood and anxiety disorders in women with PCOS. Steroids. 2012 Mar 10;77(4):338–341.
   PubMed Web of Science ®Google Scholar
• Bazarganipour F, Ziaei S, Montazeri A, et al. Predictive factors of health-related quality of life in patients with polycystic ovary syndrome: a structural equation modeling approach. Fertil Steril. 2013 Nov;100(5):1389–1396.
   PubMed Web of Science ®Google Scholar
• Veltman-Verhulst SM, Boivin J, Eijkemans MJ, et al. Emotional distress is a common risk in women with polycystic ovary syndrome: a systematic review and meta-analysis of 28 studies. Hum Reprod Update. 2012 Nov-Dec;18(6):638–651.
   PubMed Web of Science ®Google Scholar
• Palomba S, Santagni S, Falbo A, et al. Complications and challenges associated with polycystic ovary syndrome: current perspectives. Int J Womens Health. 2015 Jul 31;7:745–763.
   PubMed Web of Science ®Google Scholar
• Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2013 Dec 18;6:1–13.
   PubMed Web of Science ®Google Scholar
• Welt CK, Duran JM. Genetics of polycystic ovary syndrome. Semin Reprod Med. 2014 May;32(3):177–182.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Piperi C. Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth. Hum Reprod Update. 2005 Nov-Dec;11(6):631–643.
   PubMed Web of Science ®Google Scholar
• Jones MR, Brower MA, Xu N, et al. Systems genetics reveals the functional context of PCOS Loci and identifies genetic and molecular mechanisms of disease heterogeneity. Plos Genet. 2015 Aug 25;11(8):e1005455.
   PubMed Web of Science ®Google Scholar
• Chen ZJ, Zhao H, He L, et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet. 2011 Jan;43(1):55–59.
   PubMed Web of Science ®Google Scholar
• Shi Y, Zhao H, Shi Y, et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat Genet. 2012 Sep;44(9):1020–1025.
   PubMed Web of Science ®Google Scholar
• Lee H, Oh JY, Sung YA, et al. Genome-wide association study identified new susceptibility loci for polycystic ovary syndrome. Hum Reprod. 2015 Mar;30(3):723–731.
   PubMed Web of Science ®Google Scholar
• Hayes MG, Urbanek M, Ehrmann DA, et al. Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations. Nat Commun. 2015 Aug 18;6:7502.
   PubMed Web of Science ®Google Scholar
• Saxena R, Georgopoulos NA, Braaten TJ, et al. Han Chinese polycystic ovary syndrome risk variants in women of European ancestry: relationship to FSH levels and glucose tolerance. Hum Reprod. 2015 Jun;30(6):1454–1459.
   PubMed Web of Science ®Google Scholar
• Abbott DH, Dumesic DA, Franks S. Developmental origin of polycystic ovary syndrome - a hypothesis. J Endocrinol. 2002 Jul;174(1):1–5.
   PubMed Web of Science ®Google Scholar
• Abbott DH, Bacha F. Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood. Fertil Steril. 2013 Jul;100(1):2–11.
   PubMed Web of Science ®Google Scholar
• de Melo AS, Dias SV, Cavalli Rde C, et al. Pathogenesis of polycystic ovary syndrome: multifactorial assessment from the foetal stage to menopause. Reproduction. 2015 Jul;150(1):R11–R24.
   PubMed Web of Science ®Google Scholar
• Rae M, Grace C, Hogg K, et al. The pancreas is altered by in utero androgen exposure: implications for clinical conditions such as polycystic ovary syndrome (PCOS). Plos One. 2013;8(2):e56263.
   PubMed Web of Science ®Google Scholar
• Nohara K, Waraich RS, Liu S, et al. Developmental androgen excess programs sympathetic tone and adipose tissue dysfunction and predisposes to a cardiometabolic syndrome in female mice. Am J Physiol Endocrinol Metab. 2013 Jun 15;304(12):E1321–E1330.
   PubMed Web of Science ®Google Scholar
• Gur EB, Karadeniz M, Turan GA. Fetal programming of polycystic ovary syndrome. World J Diabetes. 2015 Jul 10;6(7):936–942.
   PubMed Web of Science ®Google Scholar
• Crisosto N, Echiburú B, Maliqueo M, et al. Improvement of hyperandrogenism and hyperinsulinemia during pregnancy in women with polycystic ovary syndrome: possible effect in the ovarian follicular mass of their daughters. Fertil Steril. 2012 Jan;97(1):218–224.
   PubMed Web of Science ®Google Scholar
• Barra R, Cruz G, Mayerhofer A, et al. Maternal sympathetic stress impairs follicular development and puberty of the offspring. Reproduction. 2014 Aug;148(2):137–145.
   PubMed Web of Science ®Google Scholar
• Boersma GJ, Bale TL, Casanello P, et al. Long-term impact of early life events on physiology and behaviour. J Neuroendocrinol. 2014 Sep;26(9):587–602.
   PubMed Web of Science ®Google Scholar
• Dumesic DA, Richards JS. Ontogeny of the ovary in polycystic ovary syndrome. Fertil Steril. 2013 Jul;100(1):23–38.
   PubMed Web of Science ®Google Scholar
• Webber LJ, Stubbs S, Stark J, et al. Formation and early development of follicles in the polycystic ovary. Lancet. 2003 Sep 27;362(9389):1017–1021.
   PubMed Web of Science ®Google Scholar
• Hoang YD, McTavish KJ, Chang RJ, et al. Paracrine regulation of theca androgen production by granulosa cells in the ovary. Fertil Steril. 2013 Aug;100(2):561–567.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Papavassiliou AG. Molecular mechanisms of insulin resistance in polycystic ovary syndrome. Trends Mol Med. 2006 Jul;12(7):324–332.
   PubMed Web of Science ®Google Scholar
• Rice S, Christoforidis N, Gadd C, et al. Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from anovulatory women with polycystic ovaries. Hum Reprod. 2005 Feb;20(2):373–381.
   PubMed Web of Science ®Google Scholar
• Comim FV, Hardy K, Franks S, et al. Adiponectin and its receptors in the ovary: further evidence for a link between obesity and hyperandrogenism in polycystic ovary syndrome. PLoS One. 2013 Nov 18;8(11):e80416.
   PubMed Web of Science ®Google Scholar
• Karlsson C, Lindell K, Svensson E, et al. Expression of functional leptin receptors in the human ovary. J Clin Endocrinol Metab. 1997 Dec;82(12):4144–4148.
   PubMed Web of Science ®Google Scholar
• Brzechffa PR, Jakimiuk AJ, Agarwal SK, et al. Serum immunoreactive leptin concentrations in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1996 Nov;81(11):4166–4169.
   PubMed Web of Science ®Google Scholar
• Li MG, Ding GL, Chen XJ, et al. Association of serum and follicular fluid leptin concentrations with granulosa cell phosphorylated signal transducer and activator of transcription 3 expression in fertile patients with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2007 Dec;92(12):4771–4776. Epub 2007 Sep 25.
   PubMed Web of Science ®Google Scholar
• Spritzer PM, Lecke SB, Satler F, et al. Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome. Reproduction. 2015 May;149(5):R219–R227.
   PubMed Web of Science ®Google Scholar
• Phelan N, O’Connor A, Kyaw Tun T, et al. Leucocytosis in women with polycystic ovary syndrome (PCOS) is incompletely explained by obesity and insulin resistance. Clin Endocrinol (Oxf). 2013 Jan;78(1):107–113.
   PubMed Web of Science ®Google Scholar
• Papalou O, Livadas S, Karachalios A, et al. White blood cells levels and PCOS: direct and indirect relationship with obesity and insulin resistance, but not with hyperandogenemia. Hormones (Athens). 2015 Jan-Mar;14(1):91–100.
   PubMedGoogle Scholar
• Escobar-Morreale HF, Luque-Ramirez M, Gonzalez F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril. 2011 Mar 1;95(3):1048–1058.
   Web of Science ®Google Scholar
• Escobar-Morreale HF, Botella-Carretero JI, Villuendas G, et al. Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity. J Clin Endocrinol Metab. 2004 Feb;89(2):806–811.
   PubMed Web of Science ®Google Scholar
• Tarkun I, Arslan BC, Canturk Z, et al. Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation. J Clin Endocrinol Metab. 2004 Nov;89(11):5592–5596.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Paterakis T, Kandarakis HA. Indices of low-grade inflammation in polycystic ovary syndrome. Ann N Y Acad Sci. 2006 Dec;1092:175–186.
   PubMed Web of Science ®Google Scholar
• Murri M, Luque-Ramírez M, Insenser M, et al. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update. 2013 May-Jun;19(3):268–288.
   PubMed Web of Science ®Google Scholar
• Qiao J, Feng HL. Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Hum Reprod Update. 2011 Jan-Feb;17(1):17–33.
   PubMed Web of Science ®Google Scholar
• Agarwal A, Aponte-Mellado A, Premkumar BJ, et al. The effects of oxidative stress on female reproduction: a review. Reprod Biol Endocrinol. 2012;10:49.
   PubMed Web of Science ®Google Scholar
• Hyderali BN, Mala K. Oxidative stress and cardiovascular complications in polycystic ovarian syndrome. Eur J Obstet Gynecol Reprod Biol. 2015 Aug;191:15–22.
   PubMed Web of Science ®Google Scholar
• Yildiz BO, Azziz R. The adrenal and polycystic ovary syndrome. Rev Endocr Metab Disord. 2007 Dec;8(4):331–342.
   PubMed Web of Science ®Google Scholar
• Pasquali R, Gambineri A. Cortisol and the polycystic ovary syndrome. Expert Rev Endocrinol Metab. 2012;7(5):555–566.
   PubMedGoogle Scholar
• Sverrisdóttir YB, Mogren T, Kataoka J, et al. Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth? Am J Physiol Endocrinol Metab. 2008 Mar;294(3):E576–E581.
   PubMed Web of Science ®Google Scholar
• Saranya K, Pal GK, Habeebullah S, et al. Assessment of cardiovascular autonomic function in patients with polycystic ovary syndrome. Obstet Gynaecol Res. 2014 Jan;40(1):192–199.
   PubMed Web of Science ®Google Scholar
• Lambert EA, Teede H, Sari CI, et al. Sympathetic activation and endothelial dysfunction in polycystic ovary syndrome are not explained by either obesity or insulin resistance. Clin Endocrinol (Oxf). 2015 cited 2015 April 27;83:812–819. DOI:10.1111/cen.12803
   PubMed Web of Science ®Google Scholar
• Kuppusamy S, Pal GK, Habeebullah S, et al. Association of sympathovagal imbalance with cardiovascular risks in patients with polycystic ovary syndrome. Endocr Res. 2015;40(1):37–43.
   PubMed Web of Science ®Google Scholar
• Lansdown A, Rees DA. The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target? Clin Endocrinol (Oxf). 2012 Dec;77(6):791–801.
   PubMed Web of Science ®Google Scholar
• Jedel E, Labrie F, Odén A, et al. Impact of electro-acupuncture and physical exercise on hyperandrogenism and oligo/amenorrhea in women with polycystic ovary syndrome: a randomized controlled trial. Am J Physiol Endocrinol Metab. 2011 Jan;300(1):E37–E45.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Christakou C, Marinakis E. Phenotypes and enviromental factors: their influence in PCOS. Curr Pharm Des. 2012;18(3):270–282.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E. Role of obesity and adiposity in polycystic ovary syndrome. Int J Obes (Lond). 2007 Nov;31(Suppl 2):SS8-SS2.
   PubMed Web of Science ®Google Scholar
• Gambineri A, Patton L, Altieri P, et al. Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study. Diabetes. 2012 Sep;61(9):2369–2374.
   PubMed Web of Science ®Google Scholar
• Tosi F, Di Sarra D, Kaufman JM, et al. Total body fat and central fat mass independently predict insulin resistance but not hyperandrogenemia in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2015 Feb;100(2):661–669.
   PubMed Web of Science ®Google Scholar
• Ressler IB, Grayson BE, Ulrich-Lai YM, et al. Diet-induced obesity exacerbates metabolic and behavioral effects of polycystic ovary syndrome in a rodent model. Am J Physiol Endocrinol Metab. 2015 Jun 15;308(12):E1076–E1084.
   PubMed Web of Science ®Google Scholar
• Spritzer PM, Motta AB, Sir-Petermann T, et al. Novel strategies in the management of polycystic ovary syndrome. Minerva Endocrinol. 2015 Sep;40(3):195–212. Epub 2015 Mar 17.
   PubMed Web of Science ®Google Scholar
• Merhi Z. Advanced glycation end products and their relevance in female reproduction. Hum Reprod. 2014 Jan;29(1):135–145.
   PubMed Web of Science ®Google Scholar
• Salama AA, Amine EK, Salem HA. Abd El Fattah NK anti-inflammatory dietary combo in overweight and obese women with polycystic ovary syndrome. N Am J Med Sci. 2015 Jul;7(7):310–316.
   PubMedGoogle Scholar
• Palimeri S, Palioura E, Diamanti-Kandarakis E. Current perspectives on the health risks associated with the consumption of advanced glycation end products: recommendations for dietary management. Diabetes Metab Syndr Obes. 2015;8:415–426.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Katsikis I, Piperi C, et al. Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf). 2008 Oct;69(4):634–641.
   PubMed Web of Science ®Google Scholar
• Kandaraki E, Chatzigeorgiou A, Piperi C, et al. Reduced ovarian glyoxalase-I activity by dietary glycotoxins and androgen excess: a causative link to polycystic ovarian syndrome. Mol Med. 2012 Oct;24(18):1183–1189.
   Google Scholar
• Diamanti-Kandarakis E, Piperi C, Patsouris E, et al. Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries. Histochem Cell Biol. 2007 Jun;127(6):581–589.
   PubMed Web of Science ®Google Scholar
• Chatzigeorgiou A, Kandaraki E, Piperi C, et al. Dietary glycotoxins affect scavenger receptor expression and the hormonal profile of female rats. J Endocrinol. 2013 Aug 29;218(3):331–337.
   PubMed Web of Science ®Google Scholar
• Ottum MS, Mistry AM. Advanced glycation end-products: modifiable environmental factors profoundly mediate insulin resistance. J Clin Biochem Nutr. 2015 Jul;57(1):1–12.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Chatzigeorgiou A, Papageorgiou E, et al. Advanced glycation end-products and insulin signaling in granulosa cells. Exp Biol Med (Maywood). 2016 Jul;241(13):1438–1445.
   PubMed Web of Science ®Google Scholar
• Ramasamy R, Yan SF, Schmidt AM. Advanced glycation endproducts: from precursors to RAGE: round and round we go. Amino Acids. 2012 Apr;42(4):1151–1161.
   PubMed Web of Science ®Google Scholar
• Tantalaki E, Piperi C, Livadas S, et al. Impact of dietary modification of advanced glycation end products (AGEs) on the hormonal and metabolic profile of women with polycystic ovary syndrome (PCOS). Hormones (Athens). 2014 Jan-Mar;13(1):65–73.
   PubMedGoogle Scholar
• Domecq JP, Prutsky G, Mullan RJ, et al. Lifestyle modification programs in polycystic ovary syndrome: systematic review and meta-analysis. J Clin Endocrinol Metab. 2013 Dec;98(12):4655–4663.
   PubMed Web of Science ®Google Scholar
• Conte F, Banting L, Teede HJ, et al. Mental health and physical activity in women with polycystic ovary syndrome: a brief review. Sports Med. 2015 Apr;45(4):497–504.
   PubMed Web of Science ®Google Scholar
• Banting LK, Gibson-Helm M, Polman R, et al. Physical activity and mental health in women with polycystic ovary syndrome. BMC Womens Health. 2014 Mar 27;14(1):51.
   PubMed Web of Science ®Google Scholar
• Stener-Victorin E, Holm G, Janson PO, et al. Acupuncture and physical exercise for affective symptoms and health-related quality of life in polycystic ovary syndrome: secondary analysis from a randomized controlled trial. BMC Complement Altern Med. 2013 Jun 13;13:131.
   PubMed Web of Science ®Google Scholar
• Harrison CL, Lombard CB, Moran LJ, et al. Exercise therapy in polycystic ovary syndrome: a systematic review. Hum Reprod Update. 2011 Mar-Apr;17(2):171–183.
   PubMed Web of Science ®Google Scholar
• Thomson RL, Spedding S, Buckley JD. Vitamin D in the aetiology and management of polycystic ovary syndrome. Clin Endocrinol (Oxf). 2012 Sep;77(3):343–350.
   PubMed Web of Science ®Google Scholar
• Foroozanfard F, Jamilian M, Bahmani F, et al. Calcium plus vitamin D supplementation influences biomarkers of inflammation and oxidative stress in overweight and vitamin D-deficient women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. Clin Endocrinol (Oxf). 2015 cited 2015 June 28;83:888–894. DOI:10.1111/cen.12840
   PubMed Web of Science ®Google Scholar
• Krul-Poel YH, Snackey C, Louwers Y, et al. The role of vitamin D in metabolic disturbances in polycystic ovary syndrome: a systematic review. Eur J Endocrinol. 2013 Oct 23;169(6):853–865.
   PubMed Web of Science ®Google Scholar
• Asemi Z, Foroozanfard F, Hashemi T, et al. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome. Clin Nutr. 2015 Aug;34(4):586–592.
   PubMed Web of Science ®Google Scholar
• Irani M, Minkoff H, Seifer DB, et al. Vitamin D increases serum levels of the soluble receptor for advanced glycation end products in women with PCOS. J Clin Endocrinol Metab. 2014 May;99(5):E886–E890.
   PubMed Web of Science ®Google Scholar
• Asemi Z, Jamilian M, Mesdaghinia E, et al. Effects of selenium supplementation on glucose homeostasis, inflammation, and oxidative stress in gestational diabetes: randomized, double-blind, placebo-controlled trial. Nutrition. 2015 Oct;31(10):1235–1242.
   PubMed Web of Science ®Google Scholar
• Razavi M, Jamilian M, Kashan ZF, et al. Selenium supplementation and the effects on reproductive outcomes, biomarkers of inflammation, and oxidative stress in women with polycystic ovary syndrome. Horm Metab Res. 2016 Mar;48(3):185–190.
   Web of Science ®Google Scholar
• Bahmani F, Karamali M, Shakeri H, et al. The effects of folate supplementation on inflammatory factors and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial. Clin Endocrinol (Oxf). 2014 Oct;81(4):582–587.
   PubMed Web of Science ®Google Scholar
• Rutkowska A, Rachon D. Bisphenol A (BPA) and its potential role in the pathogenesis of the polycystic ovary syndrome (PCOS). Gynecol Endocrinol. 2014 Apr;30(4):260–265.
   PubMed Web of Science ®Google Scholar
• Kandaraki E, Chatzigeorgiou A, Livadas S, et al. Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS. J Clin Endocrinol Metab. 2011 Mar;96(3):E480–E484.
   PubMed Web of Science ®Google Scholar
• Palioura E, Kandaraki E, Diamanti-Kandarakis E. Endocrine disruptors and polycystic ovary syndrome: a focus on bisphenol A and its potential pathophysiological aspects. Horm Mol Biol Clin Investig. 2014 Mar;17(3):137–144.
   PubMedGoogle Scholar
• Farkas J, Rigó A, Demetrovics Z. Psychological aspects of the polycystic ovary syndrome. Gynecol Endocrinol. 2014 Feb;30(2):95–99.
   PubMed Web of Science ®Google Scholar
• Dokras A, Clifton S, Futterweit W, et al. Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril. 2012 Jan;97(1):225–30.e2.
   PubMed Web of Science ®Google Scholar
• Jedel E, Waern M, Gustafson D, et al. Anxiety and depression symptoms in women with polycystic ovary syndrome compared with controls matched for body mass index. Hum Reprod. 2010 Feb;25(2):450–456.
   PubMed Web of Science ®Google Scholar
• Månsson M, Holte J, Landin-Wilhelmsen K, et al. Women with polycystic ovary syndrome are often depressed or anxious–a case control study. Psychoneuroendocrinology. 2008 Sep;33(8):1132–1138.
   PubMed Web of Science ®Google Scholar
• Cinar N, Kizilarslanoglu MC, Harmanci A, et al. Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome. Hum Reprod. 2011 Dec;26(12):3339–3345.
   PubMed Web of Science ®Google Scholar
• Barry JA, Kuczmierczyk AR, Hardiman PJ. Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2011 Sep;26(9):2442–2451.
   PubMed Web of Science ®Google Scholar
• Moran LJ, Deeks AA, Gibson-Helm ME, et al. Psychological parameters in the reproductive phenotypes of polycystic ovary syndrome. Hum Reprod. 2012 Jul;27(7):2082–2088.
   PubMed Web of Science ®Google Scholar
• Khomami MB, Tehrani FR, Hashemi S, et al. Of PCOS symptoms, hirsutism has the most significant impact on the quality of life of Iranian women. PLoS One. 2015 Apr 15;10(4):e0123608.
   Web of Science ®Google Scholar
• Clayton WJ, Lipton M, Elford J, et al. A randomized controlled trial of laser treatment among hirsute women with polycystic ovary syndrome. Br J Dermatol. 2005 May;152(5):986–992.
   PubMed Web of Science ®Google Scholar
• Annagür BB, Tazegül A, Uguz F, et al. Biological correlates of major depression and generalized anxiety disorder in women with polycystic ovary syndrome. J Psychosom Res. 2013 Mar;74(3):244–247.
   PubMed Web of Science ®Google Scholar
• Livadas S, Chaskou S, Kandaraki AA, et al. Anxiety is associated with hormonal and metabolic profile in women with polycystic ovarian syndrome. Clin Endocrinol (Oxf). 2011 Nov;75(5):698–703.
   PubMed Web of Science ®Google Scholar
• Klimczak D, Szlendak-Sauer K, Radowicki S. Depression in relation to biochemical parameters and age in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2015 Jan;184:43–47.
   PubMed Web of Science ®Google Scholar
• Greenwood EA, Pasch LA, Shinkai K, et al. Putative role for insulin resistance in depression risk in polycystic ovary syndrome. Fertil Steril. 2015 Sep;104(3):707–714.e1.
   PubMed Web of Science ®Google Scholar
• Farrell K, Antoni MH. Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions. Fertil Steril. 2010 Oct;94(5):1565–1574.
   PubMed Web of Science ®Google Scholar
• Hart R, Doherty DA. The potential implications of a PCOS diagnosis on a woman’s long-term health using data linkage. J Clin Endocrinol Metab. 2015 Mar;100(3):911–919.
   PubMed Web of Science ®Google Scholar
• Glintborg D, Hass Rubin K, Nybo M, et al. Morbidity and medicine prescriptions in a nationwide Danish population of patients diagnosed with polycystic ovary syndrome. Eur J Endocrinol. 2015 May;172(5):627–638.
   PubMed Web of Science ®Google Scholar